HomeHealthcare & Life SciencesPharmaceuticals Myasthenia Gravis Treatment Market

South Korea Myasthenia Gravis Treatment Market Size & Outlook, 2025-2033


South Korea Myasthenia Gravis Treatment Market Insights

  • Reed Intelligence analysis indicates that the South Korea Myasthenia Gravis Treatment Market size, valued at USD 16.71 Million in 2024, is expected to expand to USD 39.78 Million by 2033.
  • The South Korea market is forecasted to expand at a CAGR of 10.12% spanning 2026–2033.
  • Ocular MG  held the leading position among By Type segments in 2024, based on market size.
  • Ocular MG  is projected to post the fastest growth rate, sustaining its position as the most attractive By Type segment during the forecast horizon.

Other Key Findings


  • In 2024, South Korea represented 0.79% of the overall global Myasthenia Gravis Treatment Market size.
  • United States is projected to lead the global Myasthenia Gravis Treatment Market size by 2033.
  • Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2033.
  • South East Asia is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 84.74 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 16.71 Million
Market Size In 2033 USD 39.78 Million
Largest segment Ocular MG 
Units Revenue in USD Million
CAGR 10.12% (2025-2033)
Segmnetation Covered
By Type
  1. Ocular MG 
  2. Congenital MG 
  3. Transient Neonatal MG
By Treatment
  1. Medication 
  2. Surgery 
  3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
  4. Plasmapheresis and Intravenous Immunoglobulin 
  5. Others
By End-User
  1. Hospitals 
  2. Clinics 
  3. Academic Research Institutes 
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports